PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · Real-Time Price · USD
0.9022
-0.0477 (-5.02%)
At close: Jan 26, 2026, 4:00 PM EST
0.8801
-0.0221 (-2.45%)
After-hours: Jan 26, 2026, 4:29 PM EST
PDS Biotechnology Market Cap
PDS Biotechnology has a market cap or net worth of $49.37 million as of January 26, 2026. Its market cap has decreased by -21.45% in one year.
Market Cap
49.37M
Enterprise Value
41.62M
1-Year Change
-21.45%
Ranking
Category
Stock Price
$0.90
Market Cap Chart
Since March 18, 2019, PDS Biotechnology's market cap has increased from $45.51M to $49.37M, an increase of 8.47%. That is a compound annual growth rate of 1.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 51.98M | 23.40% |
| Dec 31, 2025 | 42.12M | -30.92% |
| Dec 31, 2024 | 60.98M | -60.56% |
| Dec 29, 2023 | 154.61M | -58.92% |
| Dec 30, 2022 | 376.31M | 63.37% |
| Dec 31, 2021 | 230.35M | 383.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CEL-SCI | 52.89M |
| OS Therapies | 51.99M |
| NeurAxis | 50.60M |
| Aligos Therapeutics | 49.17M |
| Q32 Bio | 48.97M |
| ABVC BioPharma | 48.54M |
| iBio, Inc. | 48.46M |
| Impact BioMedical | 47.89M |